Panelists ask whether cancer care will shift toward home-administered infusions as payers push for change. Other topics in this forward-looking session include new delivery tech and practice-led solutions.
|Articles|December 22, 2011
Dr. Susan Urba Discusses Preventive Care for Patients With Chemotherapy-Induced Nausea
Advertisement
Dr. Susan Urba, University of Michigan, Comprehensive Cancer Center, who serves as Professor, Department of Internal Medicine, discusses the prevention and management of chemotherapy-induced nausea and vomiting (CINV).
In addition, Dr. Urba talks about the importance of the National Comprehensive Care Network Guidelines to guide oncologists regarding best practices for preventing CINV, which will aid patients' quality of life and provide the most cost-effective treatment with the best outcomes.
Advertisement
Related to this article
CMS finalized Transparency in Coverage updates as a researcher warns ghost rates and missing inpatient data limit payer price files.
A traditional Medicare out-of-pocket (OOP) cap could reduce beneficiaries’ costs but increase annual federal spending by $39 billion to $96 billion.
A systemic sclerosis inception cohort and 17-study meta-analysis found a nearly 5-fold increase in lung cancer risk.
MA-to-MA switching among dually eligible beneficiaries rose sharply from 2016 to 2022, AJMC study author Grace Mackleby, PhD, found.
CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
CMS finalized the mandatory GLOBE Model, tying Part B drug rebates to international prices in areas covering 25% of beneficiaries from Jan. 1, 2027.
Advertisement
Advertisement
Trending on AJMC
1
Perspectives on Health-Related Social Needs for Medicare Advantage Beneficiaries
2
Systemic Sclerosis Linked to Dramatic Rise in Lung Cancer Risk
3
Psoriasis Is Much Rarer in Indigenous Groups Worldwide
4
Closing Screening Gaps for Cardio-Kidney-Metabolic Disease
5